HCA Healthcare EVP, Chief Clinical Officer Sold Shares Worth Over $593K
HCA Healthcare's EVP and Chief Clinical Officer Michael J. Schlosser sold 1,200 shares at $494.65 each, totaling $593,582. He now directly owns 1,443 shares and indirectly holds 6,951 shares through a trust, per an SEC Form 4 filing.
How this was made
The 30-second read
Why it matters
The disclosed sale is modest and unlikely to move the stock significantly.
Market read
Minor insider sale with limited trading relevance.
What to watch
No indication of broader concerns; the executive still holds a significant number of shares.
Background
Form 4 filings disclose insider transactions; investors monitor them for signals of confidence.
Ticker impact
EVP and Chief Clinical Officer Michael J. Schlosser sold 1,200 shares for $593,582, a new Form 4 filing.
likely slight downward pressure as the market prices the insider sale
The sale is a primary disclosure but the amount is modest, limiting market impact.
Market effects
Minimal effect on healthcare sector; insider sales are routine.
None
None
Counterpoint
The sale may be unrelated to company fundamentals and could be a routine portfolio rebalancing.
Key entities
- ExecutiveMichael J. Schlosser
EVP and Chief Clinical Officer of HCA Healthcare
